Navigation Links
Current guidelines underestimate US cervical cancer incidence and older women's risk
Date:5/11/2014

Rates of cervical cancer in American women may be higher than previously thought, and the disease may arise most often at an age when adequately screened women are advised to stop getting screened. The findings come from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The results should be taken into consideration when the national guidelines for cervical cancer screening are reviewed.

Removal of the uterine cervix through a hysterectomy eliminates a woman's risk of developing cervical cancer, but previous estimates of cervical cancer rates in the United States have included these women in their calculations. "In order to make accurate estimates of the true rates of cervical cancer by age in the United States and monitor trends in the occurrence of disease, it is important to calculate the occurrence of cervical cancer only among women who are at risk," explained Anne Rositch, PhD, of the University of Maryland School of Medicine, in Baltimore.

To do so, Dr. Rositch and her colleagues analyzed hysterectomy prevalence and cervical cancer incidence from 2000 to 2009. When the researchers estimated cervical cancer rates only among women with a cervix, they found that rates of disease in older women and black women were much higher than previously reported. Overall, incidence rates were 11.7 cases per 100,000 women before correcting for hysterectomies compared with 18.6 per 100,000 after correction. Also, previous reports showed that the incidence peaks at age 40 to 44 years (15.6 cases per 100,000 women) and then levels off. After correcting for hysterectomy, though, the incidence continued to increase with age, peaking at a higher rate (27.4 cases per 100,000 women) and at an older age (65 to 69 years). The effect was most pronounced among black women, given their higher prevalence of hysterectomy than white women.

The authors noted that their findings should be considered when setting national guidelines for the appropriate age to stop screening for cervical cancer. "Current guidelines recommend exiting women with recent negative screening from routine screening at age 65 years, and yet our corrected calculations show that women just past this age have the highest rate of cervical cancer," said senior author Patti Gravitt, PhD, of the Johns Hopkins Bloomberg School of Public Health. Dr. Rositch added, "It will be important to clarify in future studies whether the continued increase in cancer rates with age and the higher rates in black women represent a failure in our screening programs or a failure of the women to be screened, so that appropriate interventions can be developed to reduce the burden of cancer in these women."


'/>"/>

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
201-748-6358
Wiley
Source:Eurekalert

Related biology news :

1. Deep ocean current may slow due to climate change, Penn research finds
2. Researchers develop antibody-targeted treatment for recurrent small-cell lung cancer
3. Math models enhance current therapies for coronary heart disease
4. Potassium current density increased sharply after 2 weeks of NSCs neural differentiation
5. Elsevier announces the launch of open access journal: Current Plant Biology
6. Early-career investigator discovers current volcanic activity under West Antarctica
7. Global ocean currents explain why Northern Hemisphere is the soggier one
8. Biological therapy with cediranib improves survival in women with recurrent ovarian cancer
9. Current pledges put over 600 million people at risk of higher water scarcity
10. Current efforts will not save the worlds most endangered cat
11. Chapman University unearths data in animal habitat selection that counters current convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
(Date:1/19/2017)... Jan. 19, 2017 Sensory Inc ... and security for consumer electronics, and i ... systems and cybersecurity solutions, today announced a global ... financial institutions worldwide to bolster security of data ... secure user authentication platforms they offer, innerCore now ...
(Date:1/12/2017)... DIEGO , Jan. 12, 2017  Trovagene, Inc. ... tumor DNA (ctDNA) technologies, today announced that it has ... Europe and the Middle East ... tests.  This milestone marks the first wave of international ... for urine and blood samples. The initial ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , February 17, 2017 ... "Biomarkers Market by Product (Consumables, Service), Type (Safety, ... (Diagnostics Development, Drug Discovery and Development, Disease-Risk) - ... market is projected to reach USD 53.34 Billion ... growing at a CAGR of 13.8% during the ...
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, ... data on its oral peptide drug candidates, PTG-100 ... of the European Crohn,s and Colitis Organization (ECCO).  ... Barcelona, Spain from February 15 ... detail preclinical data on Protagonist drug candidates PTG-100 ...
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, ... focused on venture growth investments in biotechnology and ... Josh Richardson , M.D. to Managing Director. ... companies.  He is a board observer at InfaCare ... Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence ...
(Date:2/16/2017)...   Capricor Therapeutics, Inc. (NASDAQ: ... first-in-class biological therapies for cardiac and other medical ... terminate its license agreement with the Mayo Clinic ... "Our decision to return these rights ... efforts to advance our core cell and exosome-based ...
Breaking Biology Technology: